Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Thousands of small fish defy gravity to climb Congo waterfall - 2The Best Computer games for Multiplayer Fun
- 3Santa's sleigh or the International Space Station? How to spot a bright Christmas flyby Dec. 24 and 25
- 4Curl Up With Some Hot Chocolate And Watch Mighty Car Mods Explore Japan In A Honda City Turbo II
- 5The Extraordinary Excursion of Dental Embed Innovation
- Famous Restroom Beautifying Styles For 2024
- African nations push to recognize crimes of colonialism in Algeria
- The most effective method to Examine a Cellular breakdown in the lungs Finding with Family
- Exploring the Gig Economy: Illustrations from Consultants
- Surprise! Saturn's huge moon Titan may not have a buried ocean after all
- Mystery foot suggests a second early human relative lived alongside Lucy
- Manual for extravagance SUVs for seniors
- Pick Your Favored kind of books
- A definitive Cruiser Standoff: Decision in favor of Your #1 Ride
